OneMedNet Corp (ONMD) Stock

About OneMedNet Corp

OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences. The company's operations are based out of Eden Prairie, Minnesota.

OneMedNet Corp is led by CEO Aaron Green, employs 22 people, headquartered in US, publicly traded since 2021.

OneMedNet Corp (ONMD) stock trades at $4.71 with a market capitalization of $27.44M. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.73, reflecting a net loss over the last twelve months, a negative price-to-book of -7.48, reflecting negative shareholders' equity, price-to-sales of 18.14. Over the past 52 weeks the stock has ranged between $3.61 and $24.70, and currently trades 80.9% below its 52-week high.

On profitability, OneMedNet Corp generates a return on equity (ROE) of 234.63% (not meaningful, as shareholders' equity is negative), return on capital employed of 301.31%, an operating margin of -1000.00%, a net profit margin of -584.20%.

Official website: www.onemednet.com

OneMedNet Corp by the numbers, 2020–2025

Between 2020 and 2025 OneMedNet Corp reported revenue of $1.0M rising to $1.0M, a change of 0.0% across 6 years. Compounded, revenue has grown 0.0% a year over five years, 0.0% over three, 0.0% over the last twelve months. Net profit held roughly flat to $-3.0M.

Operating margin went from -355.8% in 2020 to -711.3% in 2025, a fall of 355.5 percentage points. The most recent net margin is -584.20%. On a trailing twelve-month basis to Jun '26, revenue is $1.0M and net profit $-8.0M.

Borrowings fell from $3.0M to $1.0M, cash on hand is $0, cash from operations was $-8.0M in the latest year, positive in 0 of the last 6.

Return on equity has averaged 117.9% over five years, and was 100.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

OneMedNet Corp (ONMD) — frequently asked questions